M.D. Sass, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0000922940
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 38 positions · Total reported value $1.51B · Top-10 concentration 53.9% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 64.4% · 9 new · 13 cut · 7 exited
Active Share (vs S&P 500): 92.4% · vs QQQ: 91.2% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +10.1% · vs SPY -4.7% · Prev Value $1.32B — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2026 13F filing, M.D. Sass, LLC disclosed 38 equity positions with a combined reported value of $1.51B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.9% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q2 2026 were HSIC ($107.49M), AMZN ($95.26M), WMB ($80.85M). By sector, the heaviest allocations are Industrials 32.6%, Technology 16.8%. Versus the prior quarter, allocation shifted toward Technology (+11.1pp), Industrials (+3.9pp) and away from Other (-0.6pp), Utilities (-1.1pp).
Versus the prior quarter, M.D. Sass, LLC opened 9 new positions, trimmed 13 and fully exited 7, a turnover rate of 64.4% of positions. The portfolio's overlap with the prior quarter was 64% of names.
The largest new positions opened in Q2 2026 were ADI ($61.50M), SNDK ($49.95M), SNX ($49.78M).
Of the 7 positions fully exited versus the prior quarter, the largest were FICO ($47.21M), AON ($45.95M), CBRE ($39.35M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
Insider Transactions (Form 4)
Latest M.D. Sass, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
M.D. Sass, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 38 US equity positions with a combined value of $1.51B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-8663 (status: Approved), registered 1972-06-01
- Regulatory AUM (Form ADV): $2.06B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 72%, individual investors 21%
- Manages 2 private funds, of which 2 hedge funds
Portfolio Structure
- 38 positions · $1.51B reported value (Q2 2026)
- Top 10 holdings = 53.9% of reported value
- Largest position: HSIC (SCHEIN HENRY INC) at 7.1%
- Average position size: $39.73M
Sector Tilt
- Industrials 32.6%
- Information Technology 16.8%
- Consumer Discretionary 13.2%
- (classified holdings cover 94% of value)
Quarterly Activity
- Q2 2026: 9 new, 12 added, 13 reduced, 7 exited
- 4 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.29M | $107.49M | 7.12% | Add | |
| 2 |
|
399.70K | $95.26M | 6.31% | Add | |
| 3 |
|
1.09M | $80.85M | 5.36% | Reduce | |
| 4 |
|
270.51K | $80.81M | 5.35% | Add | |
| 5 |
|
333.37K | $80.66M | 5.34% | Reduce | |
| 6 |
|
3.14M | $76.79M | 5.09% | Reduce | |
| 7 |
|
360.45K | $76.40M | 5.06% | Add | |
| 8 |
|
363.56K | $72.94M | 4.83% | Add | |
| 9 |
|
2.85M | $72.22M | 4.78% | Reduce | |
| 10 |
|
2.35M | $70.19M | 4.65% | Add | |
| 11 |
|
836.26K | $65.56M | 4.34% | Add | |
| 12 |
|
343.46K | $64.69M | 4.28% | Add | |
| 13 |
|
107.51K | $62.00M | 4.11% | Add | |
| 14 |
|
154.85K | $61.50M | 4.07% | New | |
| 15 |
|
237.88K | $53.99M | 3.58% | Reduce | |
| 16 |
|
21.97K | $49.95M | 3.31% | New | |
| 17 |
|
186.19K | $49.78M | 3.30% | New | |
| 18 |
|
615.60K | $47.94M | 3.17% | New | |
| 19 |
|
634.61K | $47.06M | 3.12% | New | |
| 20 |
|
892.62K | $37.80M | 2.50% | Reduce | |
| 21 |
|
157.52K | $28.33M | 1.88% | New | |
| 22 |
|
161.74K | $26.41M | 1.75% | New | |
| 23 |
|
67.60K | $20.14M | 1.33% | Reduce | |
| 24 |
|
35.88K | $12.24M | 0.81% | Reduce | |
| 25 |
|
63.91K | $11.27M | 0.75% | Add | |
| 26 |
|
11.94K | $8.92M | 0.59% | Add | |
| 27 |
|
41.93K | $7.99M | 0.53% | Reduce | |
| 28 |
|
31.55K | $7.65M | 0.51% | Reduce | |
| 29 |
|
55.21K | $6.79M | 0.45% | Hold | |
| 30 |
|
12.89K | $4.84M | 0.32% | Hold | |
| 31 |
|
57.34K | $4.36M | 0.29% | Hold | |
| 32 |
|
10.52K | $3.76M | 0.25% | Add | |
| 33 |
|
28.45K | $3.50M | 0.23% | Reduce | |
| 34 |
|
2.57K | $2.96M | 0.20% | New | |
| 35 |
|
13.45K | $2.62M | 0.17% | Hold | |
| 36 |
|
5.60K | $2.09M | 0.14% | Reduce | |
| 37 |
|
9.64K | $1.93M | 0.13% | New | |
| 38 |
|
332 | $239.05K | 0.02% | Reduce | |
FAQ
What did M.D. Sass, LLC buy in 2026-Q2?
In its 2026-Q2 13F filing, M.D. Sass, LLC reported 38 equity positions worth $1.51B in aggregate; its largest disclosed positions were HSIC ($107.49M), AMZN ($95.26M), WMB ($80.85M).
How large is M.D. Sass, LLC's portfolio?
M.D. Sass, LLC reported $1.51B of long equity holdings across 38 positions as of 2026-Q2. Top-10 holdings account for 53.9% of reported value.
What is M.D. Sass, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.